Christoph Hagemeyer

Assoc Professor

  • 99 Commercial Road, Monash AMREP building Level 1, Walkway, via The Alfred Centre

    3004 Melbourne

    Australia

19992021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Monash teaching commitment

HUP3011 - Human pathology: Atherosclerosis

HUP3011 - Human pathology: Vascular biology and disease

IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy

Central Clinical School Honours program "Molecular Imaging Technology"

Biography

Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.

 

Education/Academic qualification

Chemistry, PhD, Albert Ludwigs Universitat Freiburg (Albert Ludwigs University of Freiburg)

Award Date: 1 Jun 2001

Chemistry, MSc, Albert Ludwigs Universitat Freiburg (Albert Ludwigs University of Freiburg)

Award Date: 1 Apr 1997

External positions

President, Australian Society for Medical Research (ASMR)

22 Nov 2019 → …

NHMRC Senior Research Fellow, National Health and Medical Research Council (NHMRC) (Australia)

1 Jan 201931 Dec 2023

A/Prof, RMIT University

1 Mar 2014 → …

Research area keywords

  • PET CT
  • acute MI
  • animal models of human disease
  • antibodies
  • arterial thrombosis
  • drug delivery systems
  • microbubbles
  • molecular imaging
  • platelets
  • thrombosis

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or
If you made any changes in Pure these will be visible here soon.